Genetic Variations Associated with Overall and Progression-Free Survival in Multiple Myeloma Patients Treated with Thalidomide Combinations

被引：0
|
作者：
Johnson, David C. [1 ]
Gregory, Walter M. [2 ]
Dickens, Nicholas J. [1 ]
Walker, Brian A. [1 ]
Szubert, Alex J. [2 ]
Davies, Faith E. [1 ]
Durie, Brian G. M. [3 ]
Van Ness, Brian G. [4 ]
Morgan, Gareth J. [1 ]
机构：
[1] Inst Canc Res, Sect Haematooncol, London SW3 6JB, England
[2] Univ Leeds, Leeds, W Yorkshire, England
[3] Samuel Oschin Comprehens Canc Inst, Cedars Sinai Outpatient Canc Ctr, Los Angeles, CA USA
[4] Univ Minnesota, Minneapolis, MN USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [31] Impact of lenalidomide dose on progression-free survival in patients with relapsed or refractory multiple myeloma
    Dimopoulos, M. A.
    Hussein, M.
    Swern, A. S.
    Weber, D.
    [J]. LEUKEMIA, 2011, 25 (10) : 1620 - 1626
  • [32] Baseline Systemic Inflammatory Markers Interleukin 6 and Ferritin Are Associated with Toxicities and Progression-Free Survival in Multiple Myeloma Patients Treated with Idecabtagene Vicleucel
    Hansen, Doris K.
    Peres, Lauren C.
    Freeman, Ciara L.
    Puglianini, Omar Alexis Castaneda
    Faramand, Rawan
    Oswald, Laura B.
    Reid, Kayla M.
    De Avila, Gabriel
    Blue, Brandon J.
    Grajales-Cruz, Ariel F.
    Ochoa, Jose
    Shrewsbury, Alexandria
    Powell, Cole T.
    Copponex, Christina
    Kottra, Krista H.
    Gonzalez, Rebecca
    Logue, Jennifer M.
    Khimani, Farhad
    Elmariah, Hany
    Jain, Michael D.
    Nishihori, Taiga
    Liu, Hien D.
    Brayer, Jason
    Shain, Ken H.
    Baz, Rachid
    Locke, Frederick L.
    Alsina, Melissa
    Davila, Marco L.
    [J]. BLOOD, 2022, 140 : 12778 - 12780
  • [33] High complete response rate is associated with improved progression-free and overall survival in 104 patients with multiple myeloma, treated with tandem cycle high-dose melphalan and busulfan/cytoxan, and maintenance interferon α-2 (IF) with, or without thalidomide (Thai)
    Somlo, G
    Yamamoto, N
    Carter, N
    O'Donnell, M
    Snyder, D
    Sahebi, F
    Krishnan, A
    Fung, H
    Stein, A
    Spielberger, R
    Schriber, J
    Alvarnas, J
    Chow, W
    Nademance, A
    Jasmine, Z
    Stephen, F
    [J]. BLOOD, 2003, 102 (11) : 985A - 986A
  • [34] Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Franke, Norman
    Winter, Andrew
    Chen, Christine
    Tiedemann, Rodger
    Kukreti, Vishal
    [J]. LEUKEMIA & LYMPHOMA, 2014, 55 (10) : 2284 - 2289
  • [35] Neutrophil to lymphocyte ratio (NLR) impact on the progression-free survival and overall survival of multiple myeloma patients treated with high-dose chemotherapy and autologous stem cell transplantation
    Mikulski, Damian
    Koscielny, Kacper
    Nowicki, Mateusz
    Wawrzyniak, Ewa
    Kalwas, Marta
    Kowalik, Monika
    Pryt, Mateusz
    Seczkowska, Emilia
    Swiatek, Agnieszka
    Wierzbowska, Agnieszka
    Fendler, Wojciech
    [J]. LEUKEMIA & LYMPHOMA, 2023, 64 (01) : 98 - 106
  • [36] Second Autologous Stem Cell Transplantation as Salvage Therapy for Multiple Myeloma: Impact on Progression-Free and Overall Survival
    Jimenez-Zepeda, Victor H.
    Mikhael, Joseph
    Winter, Andrew
    Franke, Norman
    Masih-Khan, Esther
    Trudel, Suzanne
    Chen, Christine
    Kukreti, Vishal
    Reece, Donna E.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (05) : 773 - 779
  • [37] Predictors of Response, Progression-Free Survival, and Overall Survival in Patients With Lung Cancer Treated With Immune Checkpoint Inhibitors
    Memmott, Regan M.
    Wolfe, Adam R.
    Carbone, David P.
    Williams, Terence M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (07) : 1086 - 1098
  • [38] Genetic Polymorphisms Associated with a Prolonged Progression-Free Survival in Patients with Metastatic Renal Cell Cancer Treated with Sunitinib
    van der Veldt, Astrid A. M.
    Eechoute, Karel
    Gelderblom, Hans
    Gietema, Jourik
    Guchelaar, Henk-Jan
    van Erp, Nielka P.
    van den Eertwegh, Alfons J. M.
    Haanen, John B.
    Mathijssen, Ron H. J.
    Wessels, Judith A. M.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (03) : 620 - 629
  • [39] ANALYSIS OF THE PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ELDERLY PATIENTS (65 YEARS OLD) WITH MULTIPLE MYELOMA PATIENTS ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION.
    Cejalvo, M. J.
    Rubio, L.
    Romero, S.
    Legarda, M.
    Jimenez, M.
    Perla, A.
    Jarque, I
    Ribas, P.
    Arnao, M.
    Andreu, R.
    Dominguez, E.
    De la Rubia, J.
    [J]. HAEMATOLOGICA, 2018, 103 : 22 - 23
  • [40] Levels of Uninvolved Immunoglobulin Predict Clinical Status and Progression-Free Survival for Multiple Myeloma Patients
    Harutyunyan, Nika M.
    Vardanyan, Suzie
    Ghermezi, Michael
    Gottlieb, Jillian
    Berenson, Ariana
    Andreu-Vieyra, Claudia
    Tang, George
    Sanchez, Eric
    Li, Mingjie
    Wang, Cathy
    Ben-Zvi, Joseph
    Garzio, Gigi
    Chen, Haiming
    Finlay, Judith
    Berenson, James R.
    [J]. BLOOD, 2014, 124 (21)
12345